UPLOAD CV

    You set the targets, hired good people, yet the deadline looms large. In a bid to rescue the situation, you get more ‘hands-on’. Yet, the tighter you hold on, checking every decision and reviewing every step, the less your team appears to step up. This pattern repeats itself across the life sciences where a missed detail can delay a therapy for months. There’s something about the pressure and constraints that exist in this environment that can make control feel like the safer bet. But is it?

    The Problem

    The truth is that accountability comes from empowerment, not oversight. When leaders tighten control under pressure, they are usually trying to safeguard an outcome. What they inadvertently end up doing is remove the element that makes a team capable of delivering: room to act.

    Most leaders respond to a wobble in performance by adding review steps or checking in more often. In regulated environments, this instinct feels justified. But teams managed this closely stop making decisions. Gallup’s 2026 research on workplace accountability found that micromanaged teams operate from fear, paralysis and confusion rather than personal responsibility, waiting to be told rather than owning the outcome. The team looks busier, but it becomes less accountable.

    John Tomtishen has spent over two decades leading teams across the cell and gene therapy sector, from Novartis, where he helped build the foundation for Kymriah, which Novartis announced in 2017 as the first FDA-approved CAR-T cell therapy, to Legend Biotech, where he joined as its fifth US employee, to his current role leading global field application and strategic alliances at Catalent. Across a large pharma company, an early-stage biotech and a leading contract development and manufacturing organisation (CDMO), he has arrived at the same principle. “If you don’t empower your teams,” he told me, “you can’t hold them accountable.”

    The Solution: Why Empowerment Comes First

    Step 1: Position People for Success, Then Step Back

    The first move is to define what success looks like, then step back from dictating how to get there. Tomtishen calls this positioning people for success. “So empowerment,” he explained, “positioning them for success… giving them the freedom to operate within the role that they’re in.”

    This works because the people closest to a problem, whether on a manufacturing line, in a regulatory submission or in a client conversation, usually see more routes to a solution than a leader operating from a distance. It also depends on the leader being someone the team trusts. Tomtishen ties this back to authenticity: “You need to show up as your real self,” he said. “When you do that, you gain trust and build trust within your team.” Without that trust, stepping back reads as neglect rather than confidence.

    Tomtishen’s own move into leadership began the same way. A lab problem came up on his watch at Novartis, and rather than escalate it, he solved it himself. “We had an issue that popped up,” he told me, “and I just go right in and resolved it. I think that’s something where I knew that I could ultimately lead teams.” He now describes putting other people in that same position as one of the most rewarding parts of his own career. “One of the most gratifying things, how I’d define success,” he said, “[is] I love putting people in positions where they’re ultimately successful.”

    Step 2: Stay Available Without Taking Over

    Empowerment does not mean disappearing. Tomtishen is specific that a leader’s job is to remain present for guidance while resisting the pull to direct every move. “You really need to empower your teams to take that step back, support them on their journey,” he said. “Always be available to provide that guidance or insight.”

    The distinction he draws is between direction and availability. Constant direction, in his experience, works against the outcome a leader wants, even when it comes from good intentions. “Giving them constant direction isn’t going to position them up for long-term success,” he told me on the Active Ingredients podcast. In practice, this means a leader answers questions, removes blockers and coaches on request, but does not pre-empt decisions the team is capable of making on its own.

    Active Ingredients Podcast CTA

    RELATED: Learn From Leaders Who’ve Solved This

    Struggling with transformation, team building or leading through change? Active Ingredients features life science executives sharing the exact frameworks they used to navigate these challenges. Real strategies from leaders who’ve made it work.

    Tomtishen ties this directly to how people learn. “You learn more from failures and challenges,” he said, “and there’s multiple different ways on how you can get there.” A leader convinced there is only one correct route to an outcome will keep intervening until the team arrives at that exact route, regardless if it was the best choice. A leader who accepts that several valid paths can coexist can let a team find its own way, treating an occasional stumble as useful information rather than a reason to step back in.

    For life science leaders managing highly technical specialists, this distinction can decide whether a team escalates everything upward or only escalates what genuinely needs a leader’s input. The second pattern frees a leader’s time for the decisions that genuinely require their seniority.

    Step 3: Let Freedom Create the Accountability

    The final step closes the loop Tomtishen opened at the start: freedom is the condition for accountability, not its opposite. “Giving them that freedom to operate,” he said, “allowed you then to hold your teams accountable to deliver on the mission, the projects, whatever they’re specifically focusing on.”

    Once a team has genuine ownership of how they work, holding them to the outcome stops feeling punitive and starts feeling fair, because they chose the path themselves. “At the end of the day,” Tomtishen said, “empowerment is what enables you to hold individuals or teams accountable.”

    For life science leaders under pressure to hit a trial milestone or a manufacturing target, this reframes accountability. It moves from a stick used after something goes wrong to a natural consequence of a team that was set up, from day one, to own its own results.

    The Evidence

    Tomtishen has carried this principle from a Novartis lab team, through Legend Biotech’s early build-out as its fifth US employee, to the client-facing teams he now leads at Catalent. In each setting, he applied the same principle: give the team ownership of the how, and hold them to the what.

    What changed was the scale he had to apply it at. Novartis, by his own estimate, employed roughly 118,000 people, a structure with enough layers that empowering a project team still left plenty of oversight above it. Legend Biotech had almost none of that structure to lean on. “How you had teams at that time wearing multiple different hats is very different,” he said. “It’s having that ability to adapt to those different environments.” At Novartis, empowerment meant carving out room to act inside a large, established system. At Legend, it meant trusting a handful of people to help build the system itself.

    The broader shift, he has found, is that this autonomy needs fuel to hold over a multi-year commercialisation journey, regardless of the size of the team applying it. “If you’re not celebrating the small wins,” he said, “you’re going to lose your team in the long run.” Done well, empowered accountability looks like a team that keeps pace without being pushed, whether that team numbers in the thousands or in single figures.

    Your Next Move

    If your team’s accountability seems to be slipping, resist the instinct to add another layer of review. Tomtishen’s own advice to future leaders is to “stay motivated, hungry… focus on that mission statement… [and] don’t be afraid to fail.” Ask yourself instead:

    1        When was the last time someone on my team made a call I would have made differently, and did I let it stand?

    2       How many decisions currently route through me that someone else is fully capable of making?

    3       Do the people I lead know what “good” looks like for their role, or only what I want them to avoid doing wrong?

    4      When someone on my team fails, is my first instinct to intervene, or to coach and let them try again?

    John Tomtishen’s full conversation on Active Ingredients covers additional ground, including the difference between a high-performing team and a genuinely cohesive one, and his three-pillar framework for career success: what you know, who you know, and how you’re known.

    Listen to the full episode.

    Fraser Dove International identifies and places senior leaders across cell and gene therapy, CDMO and biopharma organisations. If you are building a leadership team that can be trusted to own its own results, we would be glad to talk.

     


     

    Meet the Author

    Thomas Dove, CEO

    Thomas Dove is CEO and Co-Founder of Fraser Dove International. As host of the Active Ingredients podcast, Thomas interviews senior executives and industry pioneers to uncover the insights that drive successful life science organisations.

    Through his work in executive search and the hosting the Active Ingredients podcast, Thomas has developed deep expertise in identifying the leadership qualities that distinguish exceptional life science executives. He regularly writes about talent acquisition strategies, leadership development, and the evolving challenges facing C-suite professionals in the rapidly changing life sciences.

    Thomas is passionate about helping life science professionals navigate their career journeys and supporting organisations in building leadership teams that can drive innovation and growth. His insights stem from years of working closely with senior leaders across the pharmaceutical, biotechnology, and Medical Device industries.

    Outside the office, he champions family values, positive energy, and his beloved Chelsea FC.


     

    * This article is based on an interview from the Active Ingredients podcast. Hosted by Thomas Dove, the Active Ingredients Podcast dissects the very essence of exceptional leadership in the life sciences. Subscribe to the Active Ingredients podcast on Spotify, Apple Podcasts, Amazon Music and YouTube.

    Loved this article?

    Share it with your friends, family or your peers!